loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1999_079___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Johnson & Johnson Innovative Medicine

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 JANSSEN PHARMACEUTICA NV Beerse BE (1)

    filter

    01 Isoconazole (1)

    filter

    01 Belgium (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    JANSSEN PHARMACEUTICA NV Beerse BE

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Isoconazole

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 1999-079 - Rev 02
    Withdrawn by Holder
    Chemical
    2010-07-20
    2021-03-26
    1018
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-079 - Rev 02 of Janssen Pharmaceutica Nv Beerse Be

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-079 - Rev 02 of Janssen Pharmaceutica Nv Beerse Be 1

    20

    Janssen Pharmaceutica Nv Beerse Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Isoconazole, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-079 - Rev 02

    This Chemical Type CEP, issued on July 20, 2010, remains in force until March 26, 2021, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1018 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY